Asarfi Hospital Reports Strong Financial Performance Amid Market Outperformance

Asarfi Hospital, a microcap player in the hospital and healthcare services industry, has recently undergone an evaluation adjustment that reflects notable changes in its financial metrics. The company's financial performance for the quarter ending September 2025 has been characterized as very positive, with key indicators reaching new heights. Net sales peaked at Rs 44.89 crore, while PBDIT and PBT less other income also recorded their highest figures at Rs 8.87 crore and Rs 4.89 crore, respectively. The profit after tax (PAT) reached Rs 4.20 crore, contributing to an earnings per share (EPS) of Rs 2.13.
In terms of valuation, Asarfi Hospital's metrics indicate an attractive position, with a price-to-earnings (PE) ratio of 31.38 and an enterprise value to EBITDA of 16.34. The company has demonstrated a strong ability to service its debt, evidenced by a low debt-to-EBITDA ratio of 1.44 times.

Despite some challenges, including a modest return on capital employed (ROCE) of 8.65%, the overall financial landscape for Asarfi Hospital appears robust. The stock has outperformed the broader market, achieving a remarkable return of 101.84% over the past year, significantly surpassing the BSE500 index's return of 8.00%.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.